Ibrutinib: iyeza lokulwa ne-lymphoma kunye neleukemia

Umxholo

• Ixabiso
• Indlela yokuthatha
• Iziphumo ebezingalindelekanga ezinokwenzeka
• Ngubani ongafanelekanga ukuthatha

Ibrutinib sisiyobisi esinokusetyenziselwa ukunyanga i-mantle cell lymphoma kunye ne-leukemia engapheliyo ye-lymphocytic, njengoko inako ukuthintela isenzo seprotein enoxanduva lokunceda iiseli zomhlaza ukuba zikhule kwaye zande.

Eli yeza liveliswa ziilabhoratri zamachiza iJanssen phantsi kwegama lebrendi Imbruvica kwaye zingathengwa kwiikhemesti eziqhelekileyo ngohlobo lwee-capsules eziyi-140 mg.

Ixabiso

Ixabiso le-Ibrutinib lihluka phakathi kwe-39,000 kunye ne-50,000 reais, kwaye inokuthengwa ezikhemesti xa kuboniswa amayeza.

Indlela yokuthatha

Ukusetyenziswa kwe-Ibrutinib kufuneka kusoloko kukhokelwa yi-oncologist, nangona kunjalo, ukubonakaliswa ngokubanzi kwesiyobisi kubonisa ukungeniswa kweephilisi ze-4 kanye ngemini, ngakumbi kwangaxeshanye.

Njengezingxobo kufuneka kuginywe yonke, ngaphandle ukwaphula okanye ukuhlafuna, kunye iglasi yamanzi.

Iziphumo ebezingalindelekanga ezinokwenzeka

Ezinye zeziphumo ebezingalindelekanga zixhaphakileyo ze-Ibrutinib zibandakanya ukudinwa rhoqo, usulelo lwempumlo, amabala abomvu okanye mfusa kulusu, umkhuhlane, iimpawu zomkhuhlane, ukugodola kunye neentlungu zomzimba, iisono okanye umqala.

Ngubani ongafanelekanga ukuthatha

Eli chiza alichaswanga kubantwana nakwishumi elivisayo, kunye nakwizigulana ezinokwaliwa nangaliphi na icandelo lefomula. Ukongeza, akufuneki zisetyenziswe ngokudibeneyo namayeza esintu kunyango loxinzelelo oluqukethe iSt.John's Wort.

Ibrutinib akufuneki isetyenziswe ngabafazi abakhulelweyo okanye abancancisayo, ngaphandle koncedo lwengcali yokubelekisa.